Clinical Pharmacokinetics

Should the Currently Recommended Twice-Daily Dosing Still be Considered the Most Appropriate Regimen for Treating MRSA Ventilator-Associated Pneumonia with Vancomycin?
pp. 147-152(6)
Authors: Pea, Federico; Viale, Pierluigi

Antiretroviral Therapy: Pharmacokinetic Considerations in Patients with Renal or Hepatic Impairment
pp. 153-172(20)
Authors: McCabe, Sarah M.; Qing,; Slish, Judianne C.; Catanzaro, Linda M.; Sheth, Neha; DiCenzo, Robert; Morse, Gene D.

Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
pp. 173-180(8)
Authors: Isla, Arantxazu; Rodríguez-Gascón, Alicia; Trocóniz, Iñaki F.; Bueno, Lorea; Solinís, María Ángeles; Maynar, Javier; Sánchez-Izquierdo, José Ángel; Pedraz, José Luis

Application of Basic Pharmacokinetic Concepts to Analysis of Microdialysis Data: Illustration with Imipenem Muscle Distribution
pp. 181-189(9)
Authors: Dahyot, Claire; Marchand, Sandrine; Bodin, Mikael; Debeane, Bertrand; Mimoz, Olivier; Couet, William

In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine
pp. 191-202(12)
Authors: Lobo, Evelyn D.; Bergstrom, Richard F.; Reddy, Shobha; Quinlan, Tonya; Chappell, Jill; Hong, Quan; Ring, Barbara; Mary Pat Knadler,

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - in Patients Undergoing Major Orthopaedic Surgery
pp. 203-216(14)
Authors: Mueck, Wolfgang; Eriksson, Bengt I.; Bauer, Kenneth A.; Borris, Lars; Dahl, Ola E.; Fisher, William D.; Gent, Michael; Haas, Sylvia; Huisman, Menno V.; Kakkar, Ajay K.; Kälebo, Peter; Kwong, Louis M.; Misselwitz, Frank; Turpie, Alexander G.G.